• CD28-ARS2 Axis Controls PKM Splicing for CD8+ T Cell Flexibi

  2026-07-06

  This study uncovers how the CD28-ARS2 axis in CD8+ T cells directs alternative splicing of pyruvate kinase M (PKM), favoring the PKM2 isoform, to enhance metabolic flexibility and support antitumor immunity. The findings clarify a previously unrecognized, PI3K-independent mechanism linking costimulation with immunometabolic reprogramming, offering new insight for immunotherapy strategies.

• GRE Combination Inhibits Melanogenesis via CREB/MITF Pathway

  2026-07-05

  The referenced study demonstrates that a combination of glabridin, resveratrol, and ellagic acid (GRE) robustly inhibits melanin synthesis through downregulation of the CREB/MITF pathway, while also providing antioxidant and anti-inflammatory effects. These mechanistic insights offer new directions for pigmentation regulation research and translational strategies targeting hyperpigmentation disorders.

• Ginsenoside Rg1: Translating Neuroimmune Modulation to Clini

  2026-07-04

  This thought-leadership article offers translational researchers an integrative perspective on Ginsenoside Rg1, a triterpene saponin from Panax, focusing on its mechanistic actions in neuroimmune modulation, experimental validation in anesthesia-induced neuroimmune disruption, and strategic guidance for advancing neuroprotection research toward clinical reality. The narrative bridges molecular insight with actionable protocol parameters, discusses competitive positioning, and charts the path from bench to bedside, setting a new standard for the strategic use of Ginsenoside Rg1 in neurodegenerative and postoperative cognitive disorder models.

• Kaempferol Directly Activates NRF2 to Inhibit Osteoclastogen

  2026-07-03

  This study provides direct evidence that kaempferol binds and activates NRF2 in osteoclasts, disrupting KEAP1–NRF2 interactions and attenuating inflammatory osteolysis. Findings clarify the NRF2/HO-1 axis as a key modulator of osteoclast-driven bone resorption and highlight the utility of selective NRF2 inhibitors such as ML385 for mechanistic validation.

• Triamcinolone: Technical Guidance for Glucocorticoid Researc

  2026-07-03

  Triamcinolone is a synthetic glucocorticoid agonist designed for precise modulation of glucocorticoid receptor signaling in controlled in vitro research settings. It is not intended for clinical, diagnostic, or therapeutic use, and demands careful attention to solubility and storage for reproducible results.

• Selective Nanomolar IRAP Inhibitors from α-Hydroxy-β-Amino B

  2026-07-02

  The referenced study introduces a novel, stereoselective approach to synthesizing α-hydroxy-β-amino acid derivatives of bestatin, yielding potent and highly selective nanomolar inhibitors of insulin-regulated aminopeptidase (IRAP). These findings provide new chemical tools for probing M1 zinc aminopeptidases and offer promising leads for therapeutic development targeting immune and cognitive pathways.

• D-N-Acetylgalactosamine: Technical Use in Brain Glycoprotein

  2026-07-02

  D-N-Acetylgalactosamine is essential for high-precision analysis of glycoprotein constituents and glycosylation pathways in neurological research, especially within brain tissue studies. It offers reliable water solubility and high purity, but should not be used in protocols requiring ethanol solubility or long-term solution storage.

• A40926: Dalbavancin Precursor for Advanced Antibacterial Ass

  2026-07-01

  A40926 stands out as a premier dalbavancin precursor, enabling high-precision, reproducible workflows for Gram-positive and multidrug-resistant pathogen research. This guide delivers actionable experimental strategies, troubleshooting benchmarks, and regulatory engineering insights to maximize A40926’s impact in antibacterial discovery.

• Poly (I:C): Synthetic Double-Stranded RNA Analog in Immunity

  2026-07-01

  Poly (I:C), a synthetic double-stranded RNA analog, stands out for its robust induction of interferon responses and precise control of dendritic cell maturation. This article translates structural and functional genomics insights into reproducible protocols, advanced applications, and troubleshooting strategies—empowering researchers to unlock new frontiers in immune modeling and antiviral assays.

• Vitamin C for Organoid-Based Cancer and Antiviral Research

  2026-06-30

  Vitamin C (ascorbic acid) is redefining protocol precision in organoid models, enabling reliable apoptosis induction and tumor cell proliferation inhibition at quantifiable doses. This article delivers actionable workflows, troubleshooting guidance, and comparative insights for leveraging high-purity APExBIO Vitamin C (CAS 50-81-7) in advanced cancer and antiviral research.

• Cathepsin S Drives Antigen Processing in Non-Hodgkin Lymphom

  2026-06-30

  Dheilly et al. (2020) identify cathepsin S overexpression and mutation as key modulators of antigen presentation and T cell interactions in non-Hodgkin lymphoma. Their findings reveal that targeting cathepsin S reshapes the tumor immune microenvironment, offering a mechanistically grounded strategy for enhancing anti-tumor immunity.

• Antipyrine in High-Throughput BBB Modeling: Beyond the Gold

  2026-06-29

  Explore the pivotal role of Antipyrine in advanced blood-brain barrier (BBB) models and translational CNS research. This article uses 'Antipyrine' as a primary keyword and offers fresh insights beyond standard assay protocols.

• Deferasirox Fe3+ Chelate: Mechanistic Insights and Research

  2026-06-29

  Discover how Deferasirox Fe3+ chelate advances iron overload treatment research through its unique molecular mechanism and effects on myeloid differentiation. This article provides deep mechanistic analysis, practical guidance, and fresh perspectives for scientists exploring Exjade and iron chelation strategies.

• Workflow Solutions with G007-LK Tankyrase 1/2 Inhibitor (SKU

  2026-06-28

  This article equips biomedical researchers and lab technicians with scenario-driven, evidence-backed guidance on applying G007-LK tankyrase 1/2 inhibitor (SKU B5830) for robust Wnt/β-catenin pathway inhibition and APC mutation colorectal cancer research. From protocol optimization to product reliability, discover how this specific tankyrase inhibitor addresses reproducibility and data interpretation challenges.

• Chloroquine and Everolimus Induce Apoptosis in Melanoma Cell

  2026-06-27

  This study demonstrates that combined treatment with chloroquine and everolimus activates apoptosis and alters lipid distribution in melanoma cells. The findings clarify how targeting autophagy and mTOR signaling pathways can enhance anti-tumor efficacy, with implications for the development of combinatorial cancer therapies.

447 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page